K233872 is an FDA 510(k) clearance for the Daylight. This device is classified as a Computerized Behavioral Therapy Device For Anxiety Disorders (Class II - Special Controls, product code SCP).
Submitted by Big Health, Inc. (San Francisco, US). The FDA issued a Cleared decision on August 30, 2024, 267 days after receiving the submission on December 7, 2023.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5801. Computerized Behavioral Therapy Device For Psychiatric Disorders.